AU5743194A - Treatment of dermatological malignancies with biologically active peptides - Google Patents

Treatment of dermatological malignancies with biologically active peptides

Info

Publication number
AU5743194A
AU5743194A AU57431/94A AU5743194A AU5743194A AU 5743194 A AU5743194 A AU 5743194A AU 57431/94 A AU57431/94 A AU 57431/94A AU 5743194 A AU5743194 A AU 5743194A AU 5743194 A AU5743194 A AU 5743194A
Authority
AU
Australia
Prior art keywords
treatment
biologically active
active peptides
dermatological
malignancies
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU57431/94A
Other languages
English (en)
Inventor
Leonard S Jacob
W. Lee Maloy
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Magainin Pharmaceuticals Inc
Original Assignee
Magainin Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Magainin Pharmaceuticals Inc filed Critical Magainin Pharmaceuticals Inc
Publication of AU5743194A publication Critical patent/AU5743194A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A61K38/1751—Bactericidal/permeability-increasing protein [BPI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/001—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof by chemical synthesis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Marine Sciences & Fisheries (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU57431/94A 1992-12-03 1993-12-03 Treatment of dermatological malignancies with biologically active peptides Abandoned AU5743194A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US98495792A 1992-12-03 1992-12-03
US984957 1992-12-03
PCT/US1993/011885 WO1994012206A1 (en) 1992-12-03 1993-12-03 Treatment of dermatological malignancies with biologically active peptides

Publications (1)

Publication Number Publication Date
AU5743194A true AU5743194A (en) 1994-06-22

Family

ID=25531059

Family Applications (1)

Application Number Title Priority Date Filing Date
AU57431/94A Abandoned AU5743194A (en) 1992-12-03 1993-12-03 Treatment of dermatological malignancies with biologically active peptides

Country Status (5)

Country Link
EP (1) EP0671939A1 (ja)
JP (1) JPH08507749A (ja)
AU (1) AU5743194A (ja)
CA (1) CA2150946A1 (ja)
WO (1) WO1994012206A1 (ja)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9504761D0 (en) * 1995-03-09 1995-04-26 Unilever Plc Amphiphilic peptide and analogs thereof
US6066319A (en) * 1996-04-30 2000-05-23 President And Fellows Of Harvard College Drug delivery using terminal complement components
US8283315B2 (en) 1998-08-28 2012-10-09 Lytix Biopharma As Inhibition of tumour growth
GB9818938D0 (en) 1998-08-28 1998-10-21 Alpharma As Bioactive peptides
US6379903B1 (en) * 1999-10-08 2002-04-30 Sigma-Aldrich Co. Purification of recombinant proteins fused to multiple epitopes
AU2003288507A1 (en) * 2002-12-19 2004-07-14 Yitzchak Hillman Disease treatment via antimicrobial peptide inhibitors
US9044438B2 (en) 2005-06-17 2015-06-02 Yitzchak Hillman Disease treatment via antimicrobial peptides or their inhibitors
US8202835B2 (en) 2005-06-17 2012-06-19 Yitzchak Hillman Disease treatment via antimicrobial peptides or their inhibitors
CN102089320B (zh) 2008-01-24 2015-11-25 埃斯佩兰斯医药公司 溶解结构域融合构建体及其制备和使用方法
EP2168592A1 (en) * 2008-09-24 2010-03-31 Helmholtz Zentrum München Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) Antimicrobial peptides
WO2011137245A2 (en) 2010-04-30 2011-11-03 Esperance Pharmaceuticals, Inc. Lytic-peptide-her2/neu (human epidermal growth factor receptor 2) ligand conjugates and methods of use
KR20210090298A (ko) 2012-10-30 2021-07-19 에스퍼란스 파마슈티컬스, 인코포레이티드 항체/약물 컨쥬게이트 및 이의 사용 방법
US11441118B2 (en) * 2017-11-02 2022-09-13 The Board Of Trustees Of The University Of Illinois Nucleic acid and other compositions and methods for the modulation of cell membranes
CN114133429B (zh) * 2021-11-22 2022-06-24 哈尔滨吉象隆生物技术有限公司 一种杀灭肿瘤细胞的多肽及其应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4810777A (en) * 1987-03-04 1989-03-07 The United States Of America As Represented By The Department Of Health And Human Services Antimicrobial compounds
US4962277A (en) * 1988-12-09 1990-10-09 Scripps Clinic And Research Foundation Deletion analogues of magainin peptides
US5073542A (en) * 1989-06-07 1991-12-17 Magainin Sciences Inc. CPF peptide compositions and their use in inhibiting growth of target cells or a virus

Also Published As

Publication number Publication date
WO1994012206A1 (en) 1994-06-09
EP0671939A1 (en) 1995-09-20
CA2150946A1 (en) 1994-06-09
JPH08507749A (ja) 1996-08-20

Similar Documents

Publication Publication Date Title
AU9028491A (en) Iontophoretic drug delivery electrode and method of hydrating the same
AU7323994A (en) Medical pump and method of programming
AU4230196A (en) Treatment of pancreatic tumors with peptide yy and analogs thereof
EP0690673A4 (en) SYSTEMIC GENETIC TREATMENT OF TISSUE DISEASES
AU5600994A (en) Reduced and controlled surface binding of biologically active molecules
AU5743194A (en) Treatment of dermatological malignancies with biologically active peptides
GB9226832D0 (en) Pharmaceutical preparations for the treatment of psoriasis
AU5081193A (en) Treatment of gynecological malignancies with biologically active peptides
IL101587A0 (en) Biologically active peptide composition and uses therefor
AU694270B2 (en) Biologically active silicon compounds and their therapeutic and cosmetic applications
AU1636492A (en) Peptides having thrombospondin-like activity and their therapeutic use
AU7092196A (en) Administration of biologically active material
AU5340594A (en) Skin treatment
AU6251594A (en) Treatment of cancerous growths with biologically active peptides and protease inhibitors
AU5538794A (en) Biologically active compounds and process therefor
AU4980693A (en) Improvements in skin plasters
AU1720097A (en) Biologically active ureido derivatives useful in the treatment of multiple sclerosis
ZA97614B (en) Biologically active more particularly peptide molecules having a potentiating effect on the biological activity of growth hormone
AU3053595A (en) Therapeutic treatment and preparations
AU5158493A (en) Treatment of corn with expander
GB9218772D0 (en) Biologically active dermatological treatment
AU6582694A (en) Biologically active peptides
GB9310608D0 (en) Biologically active dermatological treatment
AU1192495A (en) Use of selegiline and its derivatives for the treatment of psoriasis
IL105040A0 (en) Production of biologically active ribotoxin and vectors and host cells therefor